comparemela.com

Latest Breaking News On - Clean health beauty - Page 1 : comparemela.com

AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION

Voluntary Chapter 11 Commenced to Finalize Consensual Go-Forward Plan for Amyris Core Business $190 Million Financing Commitment from Foris Ventures to Support Day-to-Day Operations EMERYVILLE,.

United statesPhilipj gundKelly franklinHan kieftenbeldCompany chapterDistrict of delaware the courtUs bankruptcy courtAmyris incClean health beautyIntrepid investment bankersSecurities exchangePrnewswire amyris incAnkura consulting groupExchange commissionPachulski stang ziehl jonesVoluntary chapter

AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE

EMERYVILLE, Calif., June 26, 2023 /PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty.

Geoffrey duykHan kieftenbeldJohn meloPricewaterhousecoopers pwPrnewswire amyris incExchange commissionAmyris incClean health beautyCompany board of directorsBusiness recovery servicesChief executive officerInterim chief executiveChief financialAmyri lab to marketBoard chairInterim chief executive officer

AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING

/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through.

Pricewaterhousecoopers pwJohn meloLab to marketAnesma groupCompany onClean health beautyBusiness recovery servicesTransformation officeCompany boardExchange commissionBoard the restructuring committeePrnewswire amyris incRestructuring committeeForis venturesChief executive officerLoan facility

AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable.

United kingdomDaniele piergentiliJohn meloLife sciences at crodaCroda international plcClean health beautyAmyris incChief executive officerPresident life sciencesMclean healthPeople positiveHealth care amp hospitalsMedical pharmaceuticalsPersonnel announcements

AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9

/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through.

Han kieftenbeldJohn meloClean health beautyAmyris incPrnewswire amyris incChief executive officerChief financial officerAmyri investor relationsMclean health

vimarsana © 2020. All Rights Reserved.